Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,976.00    60.00 (1.22%)
Bid:
4,962.00
Ask:
4,966.00
Spread: 4.00 (0.081%)
Market Cap: £2.32b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorship Changes

23 Nov 2023 07:00

RNS Number : 3776U
Morgan Sindall Group PLC
23 November 2023
 
Morgan Sindall Group plc

 

23 November 2023

 

Directorship changes

 

 

Morgan Sindall Group plc announces that Tracey Killen has notified the Board of her intention to step down as a non-executive director with effect from 31 December 2023. Jen Tippin will take over from Tracey as chair of the remuneration committee with effect from 7 December 2023.

 

Sharon Fennessy will join the Board as a non-executive director, with effect from 1 January 2024. Sharon will be a member of the nomination and audit committees and will take over as audit committee chair after the AGM in 2024.

 

Sharon is a highly accomplished FTSE financial leader with a strong track record of reporting standards at the highest level. She is currently non-executive director and member of the remuneration committee at Gowan Group Limited and non-executive director member of the audit and risk committee at John Lewis Partnership Limited. Sharon has strong strategic and commercial experience developed through her career at Diageo plc and in roles with Nortel Networks and Deloitte. 

 

Commenting on the changes, Michael Findlay, Chair of Morgan Sindall Group plc, said:

 

"I'd like to thank Tracey for her significant contribution to the Board over the last six years and wish her all the best for the future. I am delighted to welcome Sharon to the Board and look forward to working with her. Sharon brings extensive financial experience and strategic and commercial skills which will further broaden the expertise on the Board, adding valuable knowledge and insight to our discussions."

 

Ends

 

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Sharon Rolston

 

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

 

ENQUIRIES:

 

Morgan Sindall Group plc

Tel: 020 7307 9200

Michael Findlay, Chair

 

 

 

Brunswick

Tel: 020 7404 5959

 

Jonathan Glass

Nina Coad

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGUGGUPWGMP
Date   Source Headline
22nd Nov 20167:00 amRNSAnalyst and Investor Evening Reception
17th Nov 20167:00 amRNSMorgan Sindall awarded share of £300m HS2 contract
10th Nov 20162:25 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading Update
1st Nov 20162:26 pmRNSTotal Voting Rights
26th Oct 201610:40 amRNSBlock listing Interim Review
20th Oct 20168:30 amRNSAdditional Listing
3rd Oct 20167:00 amRNSAppointment of Chairman
30th Sep 201612:27 pmRNSTotal Voting Rights
31st Aug 201611:11 amRNSTotal Voting Rights
11th Aug 20167:15 amRNSHolding(s) in Company
11th Aug 20167:10 amRNSNotification of a transaction by PDMR
8th Aug 20164:56 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSDirectorate Change
2nd Aug 20167:00 amRNSHalf-year Report
29th Jul 201611:19 amRNSTotal Voting Rights
27th Jul 20169:28 amRNSHolding(s) in Company
25th Jul 20168:18 amRNSHolding(s) in Company
14th Jul 20168:49 amRNSHolding(s) in Company
8th Jul 201612:02 pmRNSPrice Monitoring Extension
30th Jun 20164:55 pmRNSDirector/PDMR Shareholding
30th Jun 20163:58 pmRNSTotal Voting Rights
29th Jun 20164:48 pmRNSDirector/PDMR Shareholding
22nd Jun 201611:22 amRNSHolding(s) in Company
14th Jun 20167:00 amRNSChange in Reporting Segments
31st May 201611:26 amRNSTotal Voting Rights
5th May 20164:03 pmRNSResult of AGM
5th May 20163:26 pmRNSResult of AGM
5th May 20167:00 amRNSAGM Trading Update
29th Apr 20161:04 pmRNSTotal Voting Rights
18th Apr 201610:13 amRNSBlock listing Interim Review
6th Apr 20161:25 pmRNSHolding(s) in Company
6th Apr 20168:40 amRNSDirector/PDMR Shareholding
31st Mar 20161:59 pmRNSTotal Voting Rights
24th Mar 201612:02 pmRNSAnnual Financial Report
3rd Mar 20164:30 pmRNSDirector/PDMR Shareholding
1st Mar 20169:24 amRNSTotal Voting Rights
26th Feb 20161:05 pmRNSDirector/PDMR Shareholding
23rd Feb 201612:16 pmRNSDividend Timetable and Home Member State
23rd Feb 20167:00 amRNSResults for the Full Year ended 31 December 2015
29th Jan 201612:01 pmRNSTotal Voting Rights
19th Jan 20161:52 pmRNSDirector Declaration
1st Dec 20151:40 pmRNSHolding(s) in Company
1st Dec 201511:52 amRNSTotal Voting Rights
10th Nov 201510:15 amRNSHolding(s) in Company
9th Nov 201510:30 amRNSDirectorate Change
2nd Nov 20157:00 amRNSTrading Update
30th Oct 20159:40 amRNSTotal Voting Rights
19th Oct 20159:50 amRNSBlocklisting Interim Review
25th Sep 201512:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.